Literature DB >> 16175895

Histopathological and ultrastructural features of dermal telangiectasias in systemic sclerosis.

Jennifer G Walker1, John Stirling, Dimitra Beroukas, Kencana Dharmapatni, David R Haynes, Malcolm D Smith, Michael J Ahern, Peter J Roberts-Thomson.   

Abstract

AIMS: To investigate the histological, ultrastructural and immunohistochemical features of the vascular lining of dermal telangiectasia, a characteristic clinical finding in scleroderma.
METHODS: Standard histological, electron microscopic and immunohistological techniques were used to examine dermal telangiectasias in five patients with limited scleroderma, the most common scleroderma variant in Caucasian populations.
RESULTS: The telangiectasias were dilated postcapillary venules located in the papillary and superficial reticular dermis. The vessel walls consisted of non-fenestrated endothelial cells surrounded by a variable number of pericytes and smooth muscle cells. There were no unique ultrastructural features. Thickened collagen fibres in the reticular or deep dermis were seen in all but one patient, although in variable and generally minimal quantities. Surrounding infiltrating inflammatory cells were scarce. No enhanced endothelial staining was obtained with antibodies directed against endoglin, endothelin, E-selectin and ICAM-1 suggesting a resting or inactivated state.
CONCLUSION: The immunohistological and ultrastructural features of the lining endothelium of established telangiectasias in long-standing, limited scleroderma appear benign. It would be of interest to examine telangiectasias in the early phase of their formation. Alternatively, other explanations need to be explored in understanding the aetiopathogenesis of telangiectasia in scleroderma.

Entities:  

Mesh:

Year:  2005        PMID: 16175895     DOI: 10.1080/00313020500033262

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  7 in total

1.  Telangiectasis in CREST syndrome and systemic sclerosis: correlation of clinical and pathological features with response to pulsed dye laser treatment.

Authors:  Shlomit Halachmi; Osama Gabari; Sarit Cohen; Romelia Koren; Dan Ben Amitai; Moshe Lapidoth
Journal:  Lasers Med Sci       Date:  2013-03-14       Impact factor: 3.161

2.  Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension.

Authors:  Ami A Shah; Fredrick M Wigley; Laura K Hummers
Journal:  J Rheumatol       Date:  2009-12-01       Impact factor: 4.666

3.  Potential biomarkers for detecting pulmonary arterial hypertension in patients with systemic sclerosis.

Authors:  Paola Coral-Alvarado; Gerardo Quintana; Maria Fernanda Garces; Libia Alexandra Cepeda; Jorge Eduardo Caminos; Federico Rondon; Antonio Iglesias-Gamarra; Jose Felix Restrepo
Journal:  Rheumatol Int       Date:  2008-12-31       Impact factor: 2.631

Review 4.  Vascular disease in scleroderma.

Authors:  Fredrick M Wigley
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

5.  Endoglin and Systemic Sclerosis: A PRISMA-driven systematic review.

Authors:  Silvia Grignaschi; Anna Sbalchiero; Giuseppe Spinozzi; Bianca Lucia Palermo; Claudia Cantarini; Chantal Nardiello; Lorenzo Cavagna; Carla Olivieri
Journal:  Front Med (Lausanne)       Date:  2022-08-18

Review 6.  The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic Sclerosis.

Authors:  Yosuke Kanno
Journal:  Int J Mol Sci       Date:  2019-01-31       Impact factor: 5.923

Review 7.  α2-Antiplasmin as a Potential Therapeutic Target for Systemic Sclerosis.

Authors:  Yosuke Kanno; En Shu
Journal:  Life (Basel)       Date:  2022-03-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.